nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Endocrine disorder—Risedronate—Paget's disease of bone	0.0121	0.0121	CcSEcCtD
Zuclopenthixol—Vertigo—Tiludronate—Paget's disease of bone	0.012	0.012	CcSEcCtD
Zuclopenthixol—Rhinorrhoea—Pamidronate—Paget's disease of bone	0.0118	0.0118	CcSEcCtD
Zuclopenthixol—Myalgia—Tiludronate—Paget's disease of bone	0.0114	0.0114	CcSEcCtD
Zuclopenthixol—Amnesia—Etidronic acid—Paget's disease of bone	0.0113	0.0113	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.00997	0.00997	CcSEcCtD
Zuclopenthixol—Dyspepsia—Tiludronate—Paget's disease of bone	0.00963	0.00963	CcSEcCtD
Zuclopenthixol—Pain—Tiludronate—Paget's disease of bone	0.00936	0.00936	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00895	0.00895	CcSEcCtD
Zuclopenthixol—Hypertonia—Risedronate—Paget's disease of bone	0.0088	0.0088	CcSEcCtD
Zuclopenthixol—Pancytopenia—Etidronic acid—Paget's disease of bone	0.00875	0.00875	CcSEcCtD
Zuclopenthixol—Injection site reaction—Zoledronate—Paget's disease of bone	0.00867	0.00867	CcSEcCtD
Zuclopenthixol—Abdominal pain—Tiludronate—Paget's disease of bone	0.00865	0.00865	CcSEcCtD
Zuclopenthixol—Asthenia—Tiludronate—Paget's disease of bone	0.00785	0.00785	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Etidronic acid—Paget's disease of bone	0.00767	0.00767	CcSEcCtD
Zuclopenthixol—Diarrhoea—Tiludronate—Paget's disease of bone	0.00749	0.00749	CcSEcCtD
Zuclopenthixol—Dizziness—Tiludronate—Paget's disease of bone	0.00724	0.00724	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.00717	0.00717	CcSEcCtD
Zuclopenthixol—Headache—Tiludronate—Paget's disease of bone	0.00686	0.00686	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Risedronate—Paget's disease of bone	0.00673	0.00673	CcSEcCtD
Zuclopenthixol—Thirst—Zoledronate—Paget's disease of bone	0.00665	0.00665	CcSEcCtD
Zuclopenthixol—Breast disorder—Risedronate—Paget's disease of bone	0.00659	0.00659	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Risedronate—Paget's disease of bone	0.00652	0.00652	CcSEcCtD
Zuclopenthixol—Nausea—Tiludronate—Paget's disease of bone	0.0065	0.0065	CcSEcCtD
Zuclopenthixol—Erythema—Etidronic acid—Paget's disease of bone	0.00642	0.00642	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Pamidronate—Paget's disease of bone	0.0064	0.0064	CcSEcCtD
Zuclopenthixol—Flatulence—Etidronic acid—Paget's disease of bone	0.00633	0.00633	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Pamidronate—Paget's disease of bone	0.0062	0.0062	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Alendronate—Paget's disease of bone	0.00619	0.00619	CcSEcCtD
Zuclopenthixol—Sweating increased—Pamidronate—Paget's disease of bone	0.00583	0.00583	CcSEcCtD
Zuclopenthixol—Leukopenia—Etidronic acid—Paget's disease of bone	0.00575	0.00575	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Zoledronate—Paget's disease of bone	0.00566	0.00566	CcSEcCtD
Zuclopenthixol—Neutropenia—Pamidronate—Paget's disease of bone	0.0056	0.0056	CcSEcCtD
Zuclopenthixol—Erythema—Alendronate—Paget's disease of bone	0.00547	0.00547	CcSEcCtD
Zuclopenthixol—Discomfort—Etidronic acid—Paget's disease of bone	0.0054	0.0054	CcSEcCtD
Zuclopenthixol—Flatulence—Alendronate—Paget's disease of bone	0.00539	0.00539	CcSEcCtD
Zuclopenthixol—Sweating increased—Zoledronate—Paget's disease of bone	0.00533	0.00533	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00531	0.00531	CcSEcCtD
Zuclopenthixol—Pancytopenia—Zoledronate—Paget's disease of bone	0.0052	0.0052	CcSEcCtD
Zuclopenthixol—Neutropenia—Zoledronate—Paget's disease of bone	0.00512	0.00512	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00508	0.00508	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00498	0.00498	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00498	0.00498	CcSEcCtD
Zuclopenthixol—Weight increased—Zoledronate—Paget's disease of bone	0.00498	0.00498	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Risedronate—Paget's disease of bone	0.00497	0.00497	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00496	0.00496	CcSEcCtD
Zuclopenthixol—Weight decreased—Zoledronate—Paget's disease of bone	0.00495	0.00495	CcSEcCtD
Zuclopenthixol—Urethral disorder—Risedronate—Paget's disease of bone	0.00494	0.00494	CcSEcCtD
Zuclopenthixol—Malaise—Alendronate—Paget's disease of bone	0.00493	0.00493	CcSEcCtD
Zuclopenthixol—Vertigo—Alendronate—Paget's disease of bone	0.00492	0.00492	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00477	0.00477	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00473	0.00473	CcSEcCtD
Zuclopenthixol—Eye disorder—Risedronate—Paget's disease of bone	0.00471	0.00471	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00471	0.00471	CcSEcCtD
Zuclopenthixol—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00471	0.00471	CcSEcCtD
Zuclopenthixol—Tinnitus—Risedronate—Paget's disease of bone	0.0047	0.0047	CcSEcCtD
Zuclopenthixol—Urethral disorder—Pamidronate—Paget's disease of bone	0.0047	0.0047	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Risedronate—Paget's disease of bone	0.00468	0.00468	CcSEcCtD
Zuclopenthixol—Myalgia—Alendronate—Paget's disease of bone	0.00466	0.00466	CcSEcCtD
Zuclopenthixol—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00461	0.00461	CcSEcCtD
Zuclopenthixol—Discomfort—Alendronate—Paget's disease of bone	0.0046	0.0046	CcSEcCtD
Zuclopenthixol—Angiopathy—Risedronate—Paget's disease of bone	0.00458	0.00458	CcSEcCtD
Zuclopenthixol—Immune system disorder—Risedronate—Paget's disease of bone	0.00456	0.00456	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00455	0.00455	CcSEcCtD
Zuclopenthixol—Arrhythmia—Risedronate—Paget's disease of bone	0.00451	0.00451	CcSEcCtD
Zuclopenthixol—Constipation—Etidronic acid—Paget's disease of bone	0.00448	0.00448	CcSEcCtD
Zuclopenthixol—Eye disorder—Pamidronate—Paget's disease of bone	0.00448	0.00448	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00445	0.00445	CcSEcCtD
Zuclopenthixol—Mental disorder—Risedronate—Paget's disease of bone	0.00442	0.00442	CcSEcCtD
Zuclopenthixol—Malnutrition—Risedronate—Paget's disease of bone	0.00439	0.00439	CcSEcCtD
Zuclopenthixol—Angiopathy—Pamidronate—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Zuclopenthixol—Immune system disorder—Pamidronate—Paget's disease of bone	0.00433	0.00433	CcSEcCtD
Zuclopenthixol—Flatulence—Risedronate—Paget's disease of bone	0.00433	0.00433	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00432	0.00432	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00432	0.00432	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00431	0.00431	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Zuclopenthixol—Urethral disorder—Zoledronate—Paget's disease of bone	0.00429	0.00429	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00429	0.00429	CcSEcCtD
Zuclopenthixol—Malnutrition—Pamidronate—Paget's disease of bone	0.00417	0.00417	CcSEcCtD
Zuclopenthixol—Erythema—Pamidronate—Paget's disease of bone	0.00417	0.00417	CcSEcCtD
Zuclopenthixol—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00414	0.00414	CcSEcCtD
Zuclopenthixol—Tension—Pamidronate—Paget's disease of bone	0.0041	0.0041	CcSEcCtD
Zuclopenthixol—Eye disorder—Zoledronate—Paget's disease of bone	0.00409	0.00409	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00407	0.00407	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00406	0.00406	CcSEcCtD
Zuclopenthixol—Nervousness—Pamidronate—Paget's disease of bone	0.00405	0.00405	CcSEcCtD
Zuclopenthixol—Angiopathy—Zoledronate—Paget's disease of bone	0.00397	0.00397	CcSEcCtD
Zuclopenthixol—Immune system disorder—Zoledronate—Paget's disease of bone	0.00396	0.00396	CcSEcCtD
Zuclopenthixol—Vertigo—Risedronate—Paget's disease of bone	0.00394	0.00394	CcSEcCtD
Zuclopenthixol—Syncope—Risedronate—Paget's disease of bone	0.00394	0.00394	CcSEcCtD
Zuclopenthixol—Dyspepsia—Alendronate—Paget's disease of bone	0.00393	0.00393	CcSEcCtD
Zuclopenthixol—Arrhythmia—Zoledronate—Paget's disease of bone	0.00391	0.00391	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00387	0.00387	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00386	0.00386	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Risedronate—Paget's disease of bone	0.00386	0.00386	CcSEcCtD
Zuclopenthixol—Mental disorder—Zoledronate—Paget's disease of bone	0.00384	0.00384	CcSEcCtD
Zuclopenthixol—Agitation—Pamidronate—Paget's disease of bone	0.00384	0.00384	CcSEcCtD
Zuclopenthixol—Pain—Alendronate—Paget's disease of bone	0.00382	0.00382	CcSEcCtD
Zuclopenthixol—Constipation—Alendronate—Paget's disease of bone	0.00382	0.00382	CcSEcCtD
Zuclopenthixol—Malnutrition—Zoledronate—Paget's disease of bone	0.00381	0.00381	CcSEcCtD
Zuclopenthixol—Erythema—Zoledronate—Paget's disease of bone	0.00381	0.00381	CcSEcCtD
Zuclopenthixol—Hypertension—Risedronate—Paget's disease of bone	0.00379	0.00379	CcSEcCtD
Zuclopenthixol—Malaise—Pamidronate—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Zuclopenthixol—Syncope—Pamidronate—Paget's disease of bone	0.00374	0.00374	CcSEcCtD
Zuclopenthixol—Myalgia—Risedronate—Paget's disease of bone	0.00374	0.00374	CcSEcCtD
Zuclopenthixol—Leukopenia—Pamidronate—Paget's disease of bone	0.00374	0.00374	CcSEcCtD
Zuclopenthixol—Anxiety—Risedronate—Paget's disease of bone	0.00372	0.00372	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00371	0.00371	CcSEcCtD
Zuclopenthixol—Pruritus—Etidronic acid—Paget's disease of bone	0.00371	0.00371	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Alendronate—Paget's disease of bone	0.00368	0.00368	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00367	0.00367	CcSEcCtD
Zuclopenthixol—Dry mouth—Risedronate—Paget's disease of bone	0.00366	0.00366	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00365	0.00365	CcSEcCtD
Zuclopenthixol—Convulsion—Pamidronate—Paget's disease of bone	0.00362	0.00362	CcSEcCtD
Zuclopenthixol—Hypertension—Pamidronate—Paget's disease of bone	0.0036	0.0036	CcSEcCtD
Zuclopenthixol—Vision blurred—Zoledronate—Paget's disease of bone	0.00359	0.00359	CcSEcCtD
Zuclopenthixol—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00359	0.00359	CcSEcCtD
Zuclopenthixol—Tremor—Zoledronate—Paget's disease of bone	0.00357	0.00357	CcSEcCtD
Zuclopenthixol—Myalgia—Pamidronate—Paget's disease of bone	0.00355	0.00355	CcSEcCtD
Zuclopenthixol—Anxiety—Pamidronate—Paget's disease of bone	0.00354	0.00354	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00354	0.00354	CcSEcCtD
Zuclopenthixol—Abdominal pain—Alendronate—Paget's disease of bone	0.00353	0.00353	CcSEcCtD
Zuclopenthixol—Body temperature increased—Alendronate—Paget's disease of bone	0.00353	0.00353	CcSEcCtD
Zuclopenthixol—Shock—Risedronate—Paget's disease of bone	0.00353	0.00353	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Risedronate—Paget's disease of bone	0.00351	0.00351	CcSEcCtD
Zuclopenthixol—Discomfort—Pamidronate—Paget's disease of bone	0.00351	0.00351	CcSEcCtD
Zuclopenthixol—Agitation—Zoledronate—Paget's disease of bone	0.0035	0.0035	CcSEcCtD
Zuclopenthixol—Skin disorder—Risedronate—Paget's disease of bone	0.00348	0.00348	CcSEcCtD
Zuclopenthixol—Malaise—Zoledronate—Paget's disease of bone	0.00344	0.00344	CcSEcCtD
Zuclopenthixol—Vertigo—Zoledronate—Paget's disease of bone	0.00343	0.00343	CcSEcCtD
Zuclopenthixol—Syncope—Zoledronate—Paget's disease of bone	0.00342	0.00342	CcSEcCtD
Zuclopenthixol—Leukopenia—Zoledronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Zuclopenthixol—Palpitations—Zoledronate—Paget's disease of bone	0.00337	0.00337	CcSEcCtD
Zuclopenthixol—Shock—Pamidronate—Paget's disease of bone	0.00335	0.00335	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00335	0.00335	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00334	0.00334	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00333	0.00333	CcSEcCtD
Zuclopenthixol—Vomiting—Etidronic acid—Paget's disease of bone	0.00333	0.00333	CcSEcCtD
Zuclopenthixol—Tachycardia—Pamidronate—Paget's disease of bone	0.00332	0.00332	CcSEcCtD
Zuclopenthixol—Rash—Etidronic acid—Paget's disease of bone	0.0033	0.0033	CcSEcCtD
Zuclopenthixol—Convulsion—Zoledronate—Paget's disease of bone	0.0033	0.0033	CcSEcCtD
Zuclopenthixol—Dermatitis—Etidronic acid—Paget's disease of bone	0.0033	0.0033	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00329	0.00329	CcSEcCtD
Zuclopenthixol—Hypertension—Zoledronate—Paget's disease of bone	0.00329	0.00329	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Alendronate—Paget's disease of bone	0.00329	0.00329	CcSEcCtD
Zuclopenthixol—Headache—Etidronic acid—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00326	0.00326	CcSEcCtD
Zuclopenthixol—Anorexia—Pamidronate—Paget's disease of bone	0.00325	0.00325	CcSEcCtD
Zuclopenthixol—Myalgia—Zoledronate—Paget's disease of bone	0.00325	0.00325	CcSEcCtD
Zuclopenthixol—Insomnia—Risedronate—Paget's disease of bone	0.00324	0.00324	CcSEcCtD
Zuclopenthixol—Anxiety—Zoledronate—Paget's disease of bone	0.00323	0.00323	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00322	0.00322	CcSEcCtD
Zuclopenthixol—Paraesthesia—Risedronate—Paget's disease of bone	0.00322	0.00322	CcSEcCtD
Zuclopenthixol—Discomfort—Zoledronate—Paget's disease of bone	0.00321	0.00321	CcSEcCtD
Zuclopenthixol—Asthenia—Alendronate—Paget's disease of bone	0.0032	0.0032	CcSEcCtD
Zuclopenthixol—Dyspnoea—Risedronate—Paget's disease of bone	0.00319	0.00319	CcSEcCtD
Zuclopenthixol—Hypotension—Pamidronate—Paget's disease of bone	0.00318	0.00318	CcSEcCtD
Zuclopenthixol—Dry mouth—Zoledronate—Paget's disease of bone	0.00317	0.00317	CcSEcCtD
Zuclopenthixol—Pruritus—Alendronate—Paget's disease of bone	0.00316	0.00316	CcSEcCtD
Zuclopenthixol—Dyspepsia—Risedronate—Paget's disease of bone	0.00315	0.00315	CcSEcCtD
Zuclopenthixol—Nausea—Etidronic acid—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.0031	0.0031	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Zuclopenthixol—Fatigue—Risedronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Zuclopenthixol—Insomnia—Pamidronate—Paget's disease of bone	0.00308	0.00308	CcSEcCtD
Zuclopenthixol—Pain—Risedronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Zuclopenthixol—Constipation—Risedronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Zuclopenthixol—Shock—Zoledronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Zuclopenthixol—Paraesthesia—Pamidronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Zuclopenthixol—Diarrhoea—Alendronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00305	0.00305	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00305	0.00305	CcSEcCtD
Zuclopenthixol—Dyspnoea—Pamidronate—Paget's disease of bone	0.00304	0.00304	CcSEcCtD
Zuclopenthixol—Tachycardia—Zoledronate—Paget's disease of bone	0.00304	0.00304	CcSEcCtD
Zuclopenthixol—Somnolence—Pamidronate—Paget's disease of bone	0.00303	0.00303	CcSEcCtD
Zuclopenthixol—Skin disorder—Zoledronate—Paget's disease of bone	0.00302	0.00302	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Zuclopenthixol—Dyspepsia—Pamidronate—Paget's disease of bone	0.003	0.003	CcSEcCtD
Zuclopenthixol—Anorexia—Zoledronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Zuclopenthixol—Decreased appetite—Pamidronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Zuclopenthixol—Dizziness—Alendronate—Paget's disease of bone	0.00295	0.00295	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00294	0.00294	CcSEcCtD
Zuclopenthixol—Fatigue—Pamidronate—Paget's disease of bone	0.00294	0.00294	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00293	0.00293	CcSEcCtD
Zuclopenthixol—Pain—Pamidronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Zuclopenthixol—Constipation—Pamidronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Zuclopenthixol—Hypotension—Zoledronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Zuclopenthixol—Vomiting—Alendronate—Paget's disease of bone	0.00284	0.00284	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Zuclopenthixol—Abdominal pain—Risedronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Zuclopenthixol—Body temperature increased—Risedronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Zuclopenthixol—Rash—Alendronate—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Zuclopenthixol—Insomnia—Zoledronate—Paget's disease of bone	0.00281	0.00281	CcSEcCtD
Zuclopenthixol—Dermatitis—Alendronate—Paget's disease of bone	0.00281	0.00281	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00281	0.00281	CcSEcCtD
Zuclopenthixol—Headache—Alendronate—Paget's disease of bone	0.0028	0.0028	CcSEcCtD
Zuclopenthixol—Paraesthesia—Zoledronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Zuclopenthixol—Dyspnoea—Zoledronate—Paget's disease of bone	0.00277	0.00277	CcSEcCtD
Zuclopenthixol—Somnolence—Zoledronate—Paget's disease of bone	0.00277	0.00277	CcSEcCtD
Zuclopenthixol—Dyspepsia—Zoledronate—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Zuclopenthixol—Decreased appetite—Zoledronate—Paget's disease of bone	0.0027	0.0027	CcSEcCtD
Zuclopenthixol—Abdominal pain—Pamidronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Zuclopenthixol—Body temperature increased—Pamidronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Zuclopenthixol—Fatigue—Zoledronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Zuclopenthixol—Constipation—Zoledronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Zuclopenthixol—Pain—Zoledronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Zuclopenthixol—Nausea—Alendronate—Paget's disease of bone	0.00265	0.00265	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Risedronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Zuclopenthixol—Asthenia—Risedronate—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00256	0.00256	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Zuclopenthixol—Pruritus—Risedronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00251	0.00251	CcSEcCtD
Zuclopenthixol—Body temperature increased—Zoledronate—Paget's disease of bone	0.00246	0.00246	CcSEcCtD
Zuclopenthixol—Abdominal pain—Zoledronate—Paget's disease of bone	0.00246	0.00246	CcSEcCtD
Zuclopenthixol—Diarrhoea—Risedronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Zuclopenthixol—Asthenia—Pamidronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Zuclopenthixol—Pruritus—Pamidronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Zuclopenthixol—Dizziness—Risedronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Zuclopenthixol—Diarrhoea—Pamidronate—Paget's disease of bone	0.00233	0.00233	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Zuclopenthixol—Vomiting—Risedronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Zuclopenthixol—Rash—Risedronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Zuclopenthixol—Dermatitis—Risedronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Zuclopenthixol—Dizziness—Pamidronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Zuclopenthixol—Headache—Risedronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Zuclopenthixol—Asthenia—Zoledronate—Paget's disease of bone	0.00223	0.00223	CcSEcCtD
Zuclopenthixol—Pruritus—Zoledronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Zuclopenthixol—Vomiting—Pamidronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Zuclopenthixol—Rash—Pamidronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Zuclopenthixol—Dermatitis—Pamidronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Zuclopenthixol—Headache—Pamidronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Zuclopenthixol—Diarrhoea—Zoledronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Zuclopenthixol—Nausea—Risedronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Zuclopenthixol—Dizziness—Zoledronate—Paget's disease of bone	0.00206	0.00206	CcSEcCtD
Zuclopenthixol—Nausea—Pamidronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Zuclopenthixol—Vomiting—Zoledronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Zuclopenthixol—Rash—Zoledronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Zuclopenthixol—Dermatitis—Zoledronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Zuclopenthixol—Headache—Zoledronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Zuclopenthixol—Nausea—Zoledronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
